Go Pro

MAIA Biotechnology (MAIA) Institutional Ownership

MAIA Biotechnology logo
$1.32 -0.01 (-0.75%)
As of 04:10 PM Eastern

Institutional Ownership Changes (13F Filings) for MAIA Biotechnology (NYSEAMERICAN:MAIA)

Current
Institutional Ownership
Percentage
5.65%
Number of
Institutional Buyers
(last 12 months)
10
Total
Institutional Inflows
(last 12 months)
$7.28M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$57.94K
Get MAIA Insider Trade Alerts

Want to know when executives and insiders are buying or selling MAIA Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

MAIA Institutional Buying and Selling by Quarter

MAIA Biotechnology Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/20/2026 Susquehanna International Group LLP35,223$51K0.0%N/A0.058%
8/14/2026 Cable Car Capital LP514,583$741K0.0%N/A0.846%
8/14/2026 Solas Capital Management LLC3,030,845$4.36M2.3%N/A4.982%
8/7/2026 BlackRock Inc.403,011$580K0.0%N/A0.663%
8/6/2026 Centric Wealth Management796,723$1.11M0.2%N/A1.310%
6/16/2026 PVG Asset Management Corp34,135$46K0.0%N/A0.056%
5/15/2026 Corsair Capital Management L.P.100,000$140K0.0%N/A0.164%
2/12/2026 Jane Street Group LLC78,757$120K0.0%N/A0.213%
2/9/2026 Geode Capital Management LLC296,740$454K0.0%+9.5%0.801%
2/4/2026 Centric Wealth Management586,398$897K0.2%+2.0%1.584%
1/23/2026 Ritholtz Wealth Management23,071$35K0.0%N/A0.062%
11/7/2025Vanguard Group Inc.1,103,145$1.70M0.0%-3.3%3.344%
8/14/2025 Jane Street Group LLC28,783$52K0.0%N/A0.087%
8/13/2025 Marshall Wace LLP16,165$29K0.0%N/A0.053%
8/12/2025 Centric Wealth Management573,398$1.03M0.2%+740.2%1.892%
8/8/2025 Geode Capital Management LLC222,183$400K0.0%+3.6%0.733%
8/6/2025 Centerpoint Advisory Group15,730$28K0.0%N/A0.052%
2/14/2025Jane Street Group LLC39,057$77K0.0%N/A0.149%
2/11/2025Halter Ferguson Financial Inc.240,818$477K0.2%-36.1%0.921%
11/16/2024Geode Capital Management LLC192,563$541K0.0%+22.9%0.760%
11/15/2024XTX Topco Ltd10,991$31K0.0%N/A0.043%
8/8/2024Ground Swell Capital LLC16,460$56K0.0%N/A0.075%
7/9/2024Mather Group LLC.12,060$41K0.0%+50,150.0%0.055%
5/20/2024Virtu Financial LLC32,487$71K0.0%N/A0.149%
10/10/2023FNY Investment Advisers LLC17,550$38K0.0%N/A0.129%
7/20/2023Naviter Wealth LLC22,168$49K0.0%N/A0.163%
2/7/2023Lynwood Capital Management Inc.250,000$878K1.1%+25.1%2.283%
1/4/2023Centric Wealth Management40,206$141K0.1%N/A0.367%


MAIA Institutional Ownership - Frequently Asked Questions

During the previous two years, 15 institutional investors and hedge funds held shares of MAIA Biotechnology. The most heavily invested institutionals were Solas Capital Management LLC ($4.36M), Vanguard Group Inc. ($1.70M), Centric Wealth Management ($1.11M), Cable Car Capital LP ($741K), BlackRock Inc. ($580K), Halter Ferguson Financial Inc. ($477K), and Geode Capital Management LLC ($454K).Learn more on MAIA Biotechnology's institutional investors.

5.65% of MAIA Biotechnology's stock is owned by institutional investors. Learn more on MAIA's institutional investor holdings.

Of the 13 institutional investors that purchased MAIA Biotechnology's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Solas Capital Management LLC ($3.03M), Centric Wealth Management ($1.31M), Cable Car Capital LP ($514.58K), BlackRock Inc. ($403.01K), Jane Street Group LLC ($146.60K), Corsair Capital Management L.P. ($100K), and Geode Capital Management LLC ($69.25K).

Institutional investors have bought a total of 5,053,532 shares in the last 24 months. This purchase volume represents approximately $7.28M in transactions.

The following institutional investors have sold MAIA Biotechnology stock in the last 24 months: Vanguard Group Inc. ($37.62K).

Institutional investors have sold a total of 37,624 shares in the last 24 months. This volume of shares sold represents approximately $57.94K in transactions.



Institutional ownership data for NYSEAMERICAN:MAIA is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/20/2026. New 13F filings are added each quarter as they're published.
From Our Partners